此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

基于心脏病分期的个性化护理与预防事件的常规护理的随机比较 (TRANSFORM)

2026年9月25日 更新者:Cleerly, Inc.

基于冠状动脉疾病分期的个性化护理与心血管事件一级预防的常规护理的随机比较

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease (CAD) Staging System-based care strategy reduces CV events compared with risk factor-based care.

研究概览

详细说明

Cardiovascular disease (CVD) persists as the leading cause of morbidity and mortality worldwide at high societal cost. The current primary CVD prevention strategy relies upon risk stratification using population health markers such as age, sex, diabetes, hypertension, dyslipidemia and tobacco use, with preventive therapy intensified in higher risk strata. Since these risk factors are indirect surrogate markers of the underlying disease, atherosclerosis, this strategy leads to treatment of individuals with risk factors who do not have atherosclerosis and failure to treat those with significant atherosclerosis who lack risk factors. The current strategy also cannot determine which individuals are inadequately treated despite effective risk factor management (residual risk). With the current approach, the CV death rate is trending upward in the US despite evidence that screening asymptomatic patients reduces CV events and the widespread availability of effective preventive therapies.

This randomized, controlled, pragmatic trial is designed to address the unmet need for better strategies to identify asymptomatic individuals at increased risk for CV events due to atherosclerosis and to personalize their treatment based on CV risk estimates using coronary artery disease (CAD) visualization and quantification.

This study enrolls patients without known symptoms of ASCVD but who are at increased risk for ASCVD due to their age and having diabetes, prediabetes or metabolic syndrome and tests the hypothesis that a CAD Staging System-based care strategy reduces CV events compared with risk factor-based care. The Cleerly CAD Staging System incorporates imaging-based evaluation for coronary atherosclerosis, algorithm-supported pharmacotherapy and personalized education about their CAD.

研究类型

介入性

注册 (估计的)

7500

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • Arizona
      • Chandler、Arizona、美国、85224
        • 招聘中
        • Chandler Clinical Trials
        • 接触:
          • Muhammad Salim, MD
      • Scottsdale、Arizona、美国、85260
        • 招聘中
        • Scottsdale Clinical Trials
        • 接触:
          • Todd Dreitzler, MD
      • Sun City、Arizona、美国、85381
        • 招聘中
        • Sun City Research
        • 接触:
          • Juan Rodriguez, MD
      • Tucson、Arizona、美国、85704
        • 招聘中
        • Noble Clinical Research
        • 接触:
          • Roxana Rodriguez, MD
    • California
      • Beverly Hills、California、美国、90210
        • 招聘中
        • Cardiovascular Research Foundation of Southern California
        • 接触:
          • Ronald P. Karlsberg, MD
      • Beverly Hills、California、美国、90211
        • 招聘中
        • Amicis Research: Beverly Hills
        • 接触:
          • Michael Levine, MD
      • Canoga Park、California、美国、91303
        • 招聘中
        • Valiance Clinical Research - Canoga Park
        • 接触:
          • Rami Shaarawy
      • Chula Vista、California、美国、91911
        • 招聘中
        • Cardiovascular Institute of San Diego
        • 接触:
          • Milind D. Parikh, MD
      • Granada Hills、California、美国、91324
        • 招聘中
        • Amicis Research: Granada Hills
        • 接触:
          • Pascal Dabel, MD
      • Huntington Park、California、美国、90255
        • 招聘中
        • Valiance Clinical Research: Huntington Park
        • 接触:
          • Philip Kim, MD
      • Indian Wells、California、美国、92210
        • 招聘中
        • HALO Diagnostics
        • 接触:
          • John F. Feller, MD
      • La Jolla、California、美国、92037
        • 招聘中
        • Scripps Health
        • 接触:
          • Elizabeth Epstein, MD
      • Lancaster、California、美国、93534
        • 招聘中
        • Chemidox Clinical Trials
        • 接触:
          • Pamela Dewar-DeSilva, MD
      • Loma Linda、California、美国、92354
        • 招聘中
        • Loma Linda University Health
        • 接触:
          • Purvi Parwani, MD
      • Long Beach、California、美国、90805
        • 招聘中
        • Long Beach Research Institute
        • 接触:
          • Ashley Duzik, MD
      • Monterey Park、California、美国、91754
        • 招聘中
        • Ace Research Institute - Monterey Park
        • 接触:
          • Yu-Hsiang Sam Lee, MD
      • Newhall、California、美国、91321
        • 招聘中
        • Amicis Research: Newhall
        • 接触:
          • Thuong Vo, MD
      • Northridge、California、美国、91324
        • 招聘中
        • Ace Research Institute: Northridge
        • 接触:
          • Richard Park, MD
      • Northridge、California、美国、91324
        • 招聘中
        • Amicis Research: Northridge
        • 接触:
          • Nana Barseghian, MD
      • Northridge、California、美国、91325
        • 招聘中
        • Ace Research Institute: Northridge #2
        • 接触:
          • William Y. Josephson, MD
      • Northridge、California、美国、91325
        • 主动,不招人
        • Northridge Clinical Trials
      • Orange、California、美国、92868
        • 招聘中
        • University of California- Irvine
        • 接触:
          • Ailin Barseghian El-Farra, MD
      • Palo Alto、California、美国、94304
        • 招聘中
        • Stanford Health Care
        • 接触:
          • Sandra Tsai, MD
      • Palo Alto、California、美国、94304
        • 招聘中
        • VA Palo Alto
        • 接触:
          • Shriram Nallamshetty, MD
      • San Fernando、California、美国、91306
        • 招聘中
        • Amicis Research: San Fernando
        • 接触:
          • Farid Yasharpour, MD
      • Tarzana、California、美国、91356
        • 招聘中
        • Valiance Clinical Research - Tarzana
        • 接触:
          • Harpreet Singh, MD
      • Torrance、California、美国、90502
        • 招聘中
        • Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center
        • 接触:
          • Suvasini Lakshmanan, MD
      • Valencia、California、美国、91355
        • 招聘中
        • Amicis Research: Valencia
        • 接触:
          • Dennis Lewis, MD
      • Valley Village、California、美国、91607
        • 招聘中
        • Concierge Clinical Trials
        • 接触:
          • Neal R. Cutler, MD
    • Colorado
      • Aurora、Colorado、美国、80045
        • 招聘中
        • University of Colorado
        • 接触:
          • Steve Simon
        • 首席研究员:
          • Steve Simon, MD
      • Denver、Colorado、美国、80218
        • 招聘中
        • St. Josephs (Intermountain Healthcare)
        • 接触:
          • Christopher Angus, MD
    • Florida
      • Boca Raton、Florida、美国、33434
        • 招聘中
        • Flourish Medical Research
        • 接触:
          • Michael Hafran, MD
      • Cross City、Florida、美国、32628
        • 招聘中
        • Apex Research
        • 接触:
          • Tamir Salmani, MD
      • Hialeah、Florida、美国、33012
        • 招聘中
        • Evolution Research Center
        • 接触:
          • Riquel Gonzalez, MD
      • Jacksonville、Florida、美国、32209
        • 招聘中
        • UF Health Jacksonville
        • 接触:
          • Luis Ortega Paz, MD
      • Miami、Florida、美国、33137
        • 招聘中
        • BioPhase Research
        • 接触:
          • Julie Cadet-Plassman, MD
      • Miami、Florida、美国、33135
        • 招聘中
        • Fiel Wellness Clinical Research LLC
        • 接触:
          • Osvaldo Caroma, MD
      • Miami、Florida、美国、33155
        • 招聘中
        • United Clinical Research
        • 接触:
          • Teresa B. Alfonso, MD
        • 接触:
          • Alfonso
      • Miami、Florida、美国、33173
        • 招聘中
        • Atlantis Clinical Research, LLC
        • 接触:
          • Leyvi Alvarado Miranda, MD
      • Miami、Florida、美国、33183
        • 招聘中
        • Farma Medical Inc.
        • 接触:
          • Ingrid Fernandez-Milian, MD
      • Miami、Florida、美国、33173
        • 招聘中
        • Baptist Health Miami Cardiac and Vascular Institute
        • 接触:
          • Jonathan Fialkow, MD
      • Miami、Florida、美国、33186
        • 招聘中
        • New Access Research and Medical Center
        • 接触:
          • Sander Fernandez, MD
      • Miami Beach、Florida、美国、33140
        • 招聘中
        • Quantum Clinical Trials
        • 接触:
          • Christopher A. Fayeghi, MD
      • Pensacola、Florida、美国、32504
        • 招聘中
        • Ascension Sacred Heart
        • 接触:
          • Rohit Amin, MD
      • Pompano Beach、Florida、美国、33060
        • 招聘中
        • Clinical Research Center of Florida
        • 接触:
          • Howard S. Koch, MD
      • Tampa、Florida、美国、33620
        • 招聘中
        • University of South Florida
        • 接触:
          • Shone Almeida, MD
    • Georgia
      • Augusta、Georgia、美国、30907
        • 招聘中
        • Aiyan Diabetes Center
        • 接触:
          • Anthony D. Turner, MD
      • Dunwoody、Georgia、美国、30338
        • 招聘中
        • Emory University
        • 接触:
          • Ambar Kulshreshtha, MD
      • Fayetteville、Georgia、美国、30214
        • 招聘中
        • Privia Medical Group Georgia LLC -Fayetteville (Javara)
        • 接触:
          • Charlotte Grayson Mathis, MD
      • Lithia Springs、Georgia、美国、30122
        • 招聘中
        • Randomize Now- Atlanta West
        • 接触:
          • Millard Collier Jr., MD
      • Macon、Georgia、美国、31210
        • 招聘中
        • Randomize Now-Burton Medical
        • 接触:
          • Frederick Burton, MD
      • Norcross、Georgia、美国、30092
        • 招聘中
        • Evergreen Clinical Trials
        • 接触:
          • Dmitriy Pelishev, MD
      • Powder Springs、Georgia、美国、30127
        • 招聘中
        • Peachtree Clinical Solutions - Noir Research Collective
        • 接触:
          • Karan Raghavan, MD
      • Riverdale、Georgia、美国、30296
        • 招聘中
        • Randomize Now, LLC - Noir Research Collective
        • 接触:
          • Claire K. Willie, MD
      • Savannah、Georgia、美国、31406
        • 招聘中
        • Privia Medical Group Georgia, LLC (Javara Inc.)
        • 接触:
          • Thomas G. Moriarity, MD
      • Thomasville、Georgia、美国、31792
        • 招聘中
        • Privia Medical Group Georgia - Thomasville (Javara)
        • 接触:
          • William L. Cooper, MD
    • Idaho
      • Meridian、Idaho、美国、83642
        • 招聘中
        • Care Institute- High Desert
        • 接触:
          • David A. Hinchman, MD
    • Illinois
      • Chicago、Illinois、美国、60611
        • 招聘中
        • Northwestern University
        • 接触:
          • Paul C. Cremer, MD
      • Glenview、Illinois、美国、60026
        • 招聘中
        • Northshore University Health System
        • 接触:
          • Amit K. Pursnani, MD
    • Indiana
      • Indianapolis、Indiana、美国、46237
        • 招聘中
        • Franciscan Physician Network- Indiana Heart Physicians
        • 接触:
          • Ryan P Daly, MD
      • Indianapolis、Indiana、美国、46202
        • 招聘中
        • Indiana Medical Research Institute
        • 接触:
          • Arshad P. Malik
    • Iowa
      • West Des Moines、Iowa、美国、50266
        • 招聘中
        • MercyOne Iowa Heart Center
        • 接触:
          • Enrico L. Martin, MD
    • Kentucky
      • Edgewood、Kentucky、美国、41017
        • 招聘中
        • St Elizabeth Health Care - CRI
        • 接触:
          • Erica Pivato, MD
      • Louisville、Kentucky、美国、40202
        • 招聘中
        • UofL Health
        • 接触:
          • Shahab Ghafghazi, MD
    • Louisiana
      • New Orleans、Louisiana、美国、70127
        • 招聘中
        • Ascension DePaul Services Research Center
        • 接触:
          • Kristen Thomas, MD
    • Maryland
      • Bowie、Maryland、美国、20715
        • 招聘中
        • Flourish Bowie dba Flourish Research
        • 接触:
          • Sara Collins, MD
      • Columbia、Maryland、美国、21045
        • 招聘中
        • KUR Research at CMP
        • 接触:
          • William Saway, MD
    • Massachusetts
      • Boston、Massachusetts、美国、02115
        • 招聘中
        • Brigham and Women's Hospital
        • 接触:
          • Ron Blankstein, MD
      • Boston、Massachusetts、美国、02114
        • 招聘中
        • Massachusetts General Hospital
        • 接触:
          • Pradeep Natarajan, MD
    • Michigan
      • Detroit、Michigan、美国、48202
        • 招聘中
        • Henry Ford Hospital
        • 接触:
          • Cori E Russell, MD
      • Ypsilanti、Michigan、美国、48917
        • 招聘中
        • Trinity Health Michigan Heart
        • 接触:
          • Ahmad Mizyed, MD
    • Minnesota
      • Minneapolis、Minnesota、美国、55407
        • 招聘中
        • Minneapolis Heart Institute Foundation
        • 接触:
          • Michael D. Miedema, MD
    • Missouri
      • St Louis、Missouri、美国、63110
        • 招聘中
        • Washington University School of Medicine
        • 接触:
          • Farhan M. Katchi, MD
      • St Louis、Missouri、美国、63136
        • 招聘中
        • Saint Louis Heart and Vascular
        • 接触:
          • Gil Vardi, MD
    • Montana
      • Kalispell、Montana、美国、59901
        • 招聘中
        • Boeson Research Kalispell
        • 接触:
          • Justin Buls, MD
      • Missoula、Montana、美国、59804
        • 招聘中
        • Boeson Research Fort Missoula
        • 接触:
          • Audrey Remmers, MD
    • Nebraska
      • Lincoln、Nebraska、美国、68506
        • 招聘中
        • Bryan Heart
        • 接触:
          • Chad E. Travers, MD
    • Nevada
      • Las Vegas、Nevada、美国、89128
        • 招聘中
        • Vector Clinical Trials
        • 接触:
          • Bharat R. Mocherla, MD
      • Las Vegas、Nevada、美国、89102
        • 招聘中
        • Southwest Medical Associates- Optum Nevada
        • 接触:
          • Tatiana O. Tsvetkova, MD
    • New Jersey
      • Flemington、New Jersey、美国、08822
        • 招聘中
        • Advanced Heart and Vascular Institute of Hunterdon
        • 接触:
          • Andrey Espinoza, MD
      • Marlton、New Jersey、美国、08053
        • 招聘中
        • Virtua Health, Inc.
        • 接触:
          • Mark T. Finch, MD
      • New Brunswick、New Jersey、美国、08901
        • 招聘中
        • Rutgers State University
        • 接触:
          • Sabahat Bokhari, MD
      • Paramus、New Jersey、美国、07652
        • 招聘中
        • The Valley Hospital
        • 接触:
          • Himanshu Gupta, MD
      • Teaneck、New Jersey、美国、07666
        • 招聘中
        • Holy Name Medical Center
        • 接触:
          • Jaffar Raza, MD
    • New York
      • Brooklyn、New York、美国、11221
        • 招聘中
        • Clindove Research
        • 接触:
          • Nelly Cohen, MD
      • Brooklyn、New York、美国、11226
        • 招聘中
        • Swift Clinical Research
        • 接触:
          • Manoj Dalmia, MD
      • Jackson Heights、New York、美国、11372
        • 招聘中
        • Rasaj Research
        • 接触:
          • Ammara Mushtaq, MD
      • Lake Success、New York、美国、11042
        • 招聘中
        • Optum- Long Island NY
        • 接触:
          • Steven Goldberg, MD
      • Mount Kisco、New York、美国、10549
        • 招聘中
        • Northwell Health Northern Westchester Hospital
        • 接触:
          • Margaret Andersen, MD
      • New York、New York、美国、10019
        • 招聘中
        • Mount Sinai West
        • 接触:
          • Waqas A Malick, MD
      • New York、New York、美国、10029
        • 招聘中
        • Mount Sinai
        • 接触:
          • Solomon Bienstock, MD
    • North Carolina
      • Chapel Hill、North Carolina、美国、27599
        • 招聘中
        • University of North Carolina at Chapel Hill
        • 接触:
          • Matthew Cavender, MD
      • Durham、North Carolina、美国、27701
        • 招聘中
        • Duke University Hospital
        • 接触:
          • William Yancy, MD
      • Durham、North Carolina、美国、27705
        • 招聘中
        • Durham Veterans Affairs Medical Center (Durham VAMC)
        • 接触:
          • Hayden Bosworth, MD
      • Fayetteville、North Carolina、美国、28304
        • 招聘中
        • Cape Fear Valley Health System (Javara Inc.)
        • 接触:
          • Nafisa Saleem, MD
      • Morehead City、North Carolina、美国、28557
        • 主动,不招人
        • West Clinical Research
      • Winston-Salem、North Carolina、美国、27157
        • 招聘中
        • Wake Forest University Health Sciences
        • 接触:
          • Michael Shapiro, MD
    • North Dakota
      • Fargo、North Dakota、美国、58102
        • 招聘中
        • Sanford Health
        • 接触:
          • David J. Clardy, MD
    • Ohio
      • Akron、Ohio、美国、44304
        • 招聘中
        • Summa Health
        • 接触:
          • Wissam Alajaji, MD
    • Oklahoma
      • Oklahoma City、Oklahoma、美国、73109
        • 招聘中
        • Medical Research International, LLC
        • 接触:
          • Joseph Grillo, MD
      • Oklahoma City、Oklahoma、美国、73007
        • 招聘中
        • Hightower Clinical
        • 接触:
          • Faisal Latif, MD
      • Tulsa、Oklahoma、美国、74104
        • 招聘中
        • Ascension St. John - Jane Phillips Medical Center
        • 接触:
          • Michael Megaly, MD
    • Pennsylvania
      • Camp Hill、Pennsylvania、美国、17011
        • 招聘中
        • Capital Area Research
        • 接触:
          • Venkatesh Nadar, MD
    • South Carolina
      • Charleston、South Carolina、美国、29425
        • 招聘中
        • Medical University of South Carolina
        • 接触:
          • Marc-Andre Cornier, MD
    • Tennessee
      • Cleveland、Tennessee、美国、37312
        • 招聘中
        • Community DPC
        • 接触:
          • Carlton Volberg, MD
      • Knoxville、Tennessee、美国、37920
        • 招聘中
        • University of Tennessee Medical Center
        • 接触:
          • Kashif A. Shaikh, MD
      • Nashville、Tennessee、美国、37202
        • 招聘中
        • TriStar Centennial Medical Center (HCA Health Care)
        • 接触:
          • David Huneycutt, MD
    • Texas
      • Abilene、Texas、美国、79601
        • 招聘中
        • Hendrick Health
        • 接触:
          • Ren Zhang, MD
      • Beaumont、Texas、美国、77702
        • 招聘中
        • Gadolin Research
        • 接触:
          • John T Fowler, MD
      • Greenville、Texas、美国、75402
        • 招聘中
        • CardioVoyage, LLC
        • 接触:
          • Marc Demyun, MD
      • Houston、Texas、美国、77025
        • 招聘中
        • Kelsey Research Foundation
        • 接触:
          • Rohan R Wagle, MD
      • Houston、Texas、美国、77004
        • 招聘中
        • Helium Research Group
        • 接触:
          • Ijeoma A. Ekeruo
      • Houston、Texas、美国、77070
        • 招聘中
        • Gulf Coast Clinical Research, LLC
        • 接触:
          • Anjani Pandya, MD
      • Houston、Texas、美国、77030
        • 招聘中
        • The Methodist Hospital, DeBakey Cardiology Associates
        • 接触:
          • Sadeer Al-Kindi, MD
      • Laredo、Texas、美国、78041
        • 招聘中
        • Aeres Clinical Research
        • 接触:
          • Amando Garza, MD
      • Lewisville、Texas、美国、75057
        • 招聘中
        • DC Clinical Research
        • 接触:
          • Moiz M. Shafiq, MD
      • McKinney、Texas、美国、75069
        • 招聘中
        • North Dallas Research Associates - Kerlo Network
        • 接触:
          • Muhammad Akram Khan, MD
      • Mesquite、Texas、美国、75149
        • 招聘中
        • SMS Clinical Research
        • 接触:
          • Salma Saiger, MD
      • San Marcos、Texas、美国、78666
        • 招聘中
        • Privia Medical Group Gulf Coast, PLLC ( Javara Inc.)
        • 接触:
          • Alan Lee, MD
      • Stephenville、Texas、美国、76401
        • 招聘中
        • Privia Medical Group- North Texas
        • 接触:
          • Benjamin Marcum, MD
    • Utah
      • West Valley City、Utah、美国、84120
        • 尚未招聘
        • Kalo Clinical Research
        • 接触:
          • William J. Walsh, MD
    • Virginia
      • Richmond、Virginia、美国、23225
        • 招聘中
        • Chippenham Johnston Willis Medical Center
        • 接触:
          • Michael Arcarese, MD
    • Washington
      • Everett、Washington、美国、98201
        • 招聘中
        • Providence Regional Medical Center Everett
        • 接触:
          • Xiaojing Jennie Shen, MD
      • Seattle、Washington、美国、98195
        • 招聘中
        • University of Washington
        • 接触:
          • Kelley Branch, MD
    • West Virginia
      • Charleston、West Virginia、美国、25304
        • 招聘中
        • Charleston Area Medical Center
        • 接触:
          • Sarah Rinehart, MD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

55年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Provided electronic or written informed consent

  2. Men > 55, women > 65 years of age

  3. Type 2 diabetes mellitus requiring pharmacologic therapy, prediabetes (most recent HbA1c 5.7 to 6.4% and/or fasting glucose 100-125 mg/dL [5.6-6.9 mmol/L]) and/or metabolic syndrome. Metabolic syndrome is defined as > 3 of the following criteria (International Diabetes Federation 2006):

    • Body mass index ≥ 27 kg/m2 or abnormal waist circumference defined as ≥ 80 cm (31.5 inches) for women, ≥ 94 cm (37 inches) for men; for South and East Asian men (e.g., Asian Indian, Chinese, Japanese) ≥ 90 cm (35.4 inches)
    • Fasting triglycerides ≥ 150 mg/dL (1.7 mmol/L) or treated hypertriglyceridemia
    • HDL-cholesterol (HDL-C) < 40 mg/dL (1.03 mmol/L) in men, <50 mg/dL (1.29 mmol/L) in women or treatment for this lipid abnormality
    • Systolic blood pressure (BP) ≥ 130 and/or diastolic BP≥ 85 mm Hg and/or treated hypertension
    • Fasting blood glucose ≥ 100 mg/dL (5.6 mmol/L) or HbA1c ≥ 5.7%
  4. Have a device (e.g., smartphone, tablet, computer) for communication with the central cardiologist-led team managing drug treatment for the personalized care group

Exclusion Criteria:

  1. History of symptomatic CVD defined as prior MI, exertional or unstable angina, ischemic stroke, claudication, arterial revascularization for atherosclerosis or other CVD being actively managed by a cardiologist, e.g. atrial fibrillation, heart failure

  2. Planned arterial revascularization

  3. Inability to complete screening CCTA or any condition that would increase the risk associated with CCTA or increase likelihood of uninterpretable scan including:

    1. eGFR < 60 mL/min/1.73 m2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) or Modification of Diet in Renal Disease (MDRD) equation (www.kidney.org/professionals/kdoqi/gfr_calculator)
    2. Allergy to iodinated contrast or history of contrast-induced nephropathy (including adverse reaction to contrast at screening CCTA) or screening laboratory values consistent with untreated hyperthyroidism. Participants with elevated thyroid-stimulating hormone (TSH) may be enrolled but should be referred to their physician for evaluation for treatment.
    3. Thyroid cancer in the previous five (5) years or planned radioactive iodine treatment
    4. Weight > 300 lbs. (136 kg) or above manufacturer-recommended limit for scanner and table at the site
    5. Inability to hold breath for > 10 seconds
    6. Active arrhythmia (atrial fibrillation, atrial flutter, frequent premature atrial, or ventricular contractions) with poorly controlled rate (i.e., > 80 beats per minute at screening or prior to CCTA)
    7. Contraindication to dosing with beta blocker or nitroglycerin on day of screening CCTA
    8. Any other factor that, in the opinion of the investigator, would increase participant risk or increase the chance of an uninterpretable CCTA
  4. Unsuitable as a trial participant in the opinion of the investigator for reasons including significant left main stenosis (e.g. ≥ 70%; site will be notified by Cleerly), other health condition with life expectancy < 3 years or being at risk of poor compliance with study procedures (e.g., active substance abuse or untreated mental illness that, in the opinion of the investigator, is likely to adversely affect adherence or retention)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Risk Factor-Based Care

The risk factor-based care group will be managed by their usual care providers, with an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. During the trial, the centralized cardiology team will monitor the provision of medications prescribed and lab values relative to guidelines, and provide feedback and education to site investigators to support optimization. CCTA results will be centrally archived and will remain blinded to the usual care provider until the end of the study.

实验性的:Cleerly Stage-Based Care

The Cleerly Stage-Based Care group will receive personalized care centrally managed by a remote cardiologist-led team. They will also receive an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. Cleerly CAD Staging System results will be discussed with participants and serve as the basis for standardized algorithm-supported pharmacotherapy & education, which will be intensified if plaque burden has progressed at 24 months.

The Cleerly CAD Staging System is software that utilizes a proprietary algorithm to identify CAD, stage the severity of CAD when present, and generate a prognostic risk score to inform treatment decisions that support CV disease prevention.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The primary objective is to compare Cleerly stage-based care with risk factor-based care on the risk of CV events.
大体时间:Through study completion- an average of 3.5 years

The primary endpoint is total (first and subsequent) events for the composite endpoint of CV death, myocardial infarction (MI), ischemic stroke, acute limb ischemia, clinically driven arterial revascularization, and hospitalization or urgent visit for heart failure.

Through study completion- an average of 3.5 years

次要结果测量

结果测量
措施说明
大体时间
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
大体时间:Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to first occurence of an event in the primary efficacy endpoint.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
大体时间:Through study completion- an average of 3.5 years

The secondary endpoints are total occurences after randomization of the primary efficacy endpoing, kidney failure, sustained estimated glomerular filtration rate (eGFR) decrease >40% from baseline, and death from renal causes.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
大体时间:Through study completion- an average of 3.5 years

The secondary endpoints are first and total occurrences after randomization of coronary death, MI, and urgent coronary revascularization.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
大体时间:Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to first occurrence of MI or ischemic stroke.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
大体时间:Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to all-cause death.

Through study completion- an average of 3.5 years

其他结果措施

结果测量
措施说明
大体时间
The safety objective is to assess harm with the 2 prevention strategies
大体时间:Through study completion- an average of 3.5 years

The safety endpoints are Adverse events (AE) leading to discontinuation of study-recommended medication (DAE), serious AE (SAE), adverse device effect (ADE).

Through study completion- an average of 3.5 years
The safety objective is to assess harm with the 2 prevention strategies
大体时间:Through study completion- an average of 3.5 years

The safety endpoints are 20-item Short Form survey (SF-20).

Through study completion- an average of 3.5 years

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 学习椅:Deepak Bhatt, MD, MPH、Mt. Sinai Heart
  • 学习椅:David J. Maron, MD, FASPC、Stanford University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年3月6日

初级完成 (估计的)

2029年3月5日

研究完成 (估计的)

2029年3月5日

研究注册日期

首次提交

2023年10月2日

首先提交符合 QC 标准的

2023年10月31日

首次发布 (实际的)

2023年11月1日

研究记录更新

最后更新发布 (实际的)

2026年9月28日

上次提交的符合 QC 标准的更新

2026年9月25日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅